Abstract
Antibodies to cholinergic receptor structures were found in 75% of 76 Finnish and 93% of 175 Swedish patients with myasthenia gravis. The amount of antibodies showed a positive correlation to the severity of the disease, and was reduced during immunosuppressive treatment, and by thymectomy. Thymoma patients had high values. The antibody was also found in the cerebrospinal fluid. Two healthy newborn babies of myasthenic mothers had antibodies during the first weeks of life, in spite of no clinical symptoms. The occurrence of IgM antibodies before IgM antibodies in two patients during the early stages of myasthenia gravis suggests that the antibody is not a primary cause of the disease.
Full text
PDF![394](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/e79b8a328336/jnnpsyc00143-0006.png)
![395](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/5f04290ea8b9/jnnpsyc00143-0007.png)
![396](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/6f143ad35478/jnnpsyc00143-0008.png)
![397](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/072e2246f30a/jnnpsyc00143-0009.png)
![398](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/b193b75d1dd5/jnnpsyc00143-0010.png)
![399](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/046d99452b11/jnnpsyc00143-0011.png)
![400](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/8abafe62b7bf/jnnpsyc00143-0012.png)
![401](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/ace7c9b65f40/jnnpsyc00143-0013.png)
![402](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/7f2f7e02c1fe/jnnpsyc00143-0014.png)
![403](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3890/493044/0568b02b5d4b/jnnpsyc00143-0015.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aharonov A., Abramsky O., Tarrab-Hazdai R., Fuchs S. Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet. 1975 Aug 23;2(7930):340–342. doi: 10.1016/s0140-6736(75)92779-8. [DOI] [PubMed] [Google Scholar]
- Almon R. R., Andrew C. G., Appel S. H. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science. 1974 Oct 4;186(4158):55–57. doi: 10.1126/science.186.4158.55. [DOI] [PubMed] [Google Scholar]
- Appel S. H., Almon R. R., Levy N. Acetylcholine receptor antibodies in myasthenia gravis. N Engl J Med. 1975 Oct 9;293(15):760–761. doi: 10.1056/NEJM197510092931508. [DOI] [PubMed] [Google Scholar]
- Bergström K., Franksson C., Matell G., von Reis G. The effect of thoracic duct lymph drainage in myasthenia gravis. Eur Neurol. 1973;9(3):157–167. doi: 10.1159/000114221. [DOI] [PubMed] [Google Scholar]
- GROB D., HARVEY A. M., JOHNS R. J. Studies in neuromuscular function. IV. Stimulating and depressant effects of acetylcholine and choline in patients with myasthenia gravis, and their relationship to the defect in neuromuscular transmission. Bull Johns Hopkins Hosp. 1956 Sep;99(3):153–181. [PubMed] [Google Scholar]
- HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lefvert A. K., Bergström K. Immunoglobulins in myasthenia gravis: effect of human lymph IgG 3 and F (ab')2 fragments on a cholinergic receptor preparation from Torpedo marmorata. Eur J Clin Invest. 1977 Apr;7(2):115–119. doi: 10.1111/j.1365-2362.1977.tb01582.x. [DOI] [PubMed] [Google Scholar]
- Lefvert A. K., Pirskanen R. Acetylcholine-receptor antibodies in cerebrospinal fluid of patients with myasthenia gravis. Lancet. 1977 Aug 13;2(8033):351–352. doi: 10.1016/s0140-6736(77)91506-9. [DOI] [PubMed] [Google Scholar]
- Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976 Nov;26(11):1054–1059. doi: 10.1212/wnl.26.11.1054. [DOI] [PubMed] [Google Scholar]
- Lindstrom J. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol. 1977 Jan;7(1):36–43. doi: 10.1016/0090-1229(77)90027-7. [DOI] [PubMed] [Google Scholar]
- Matell G., Bergström K., Franksson C., Hammarström L., Lefvert A. K., Möller E., von Reis G., Smith E. Effects of some immunosuppressive procedures on myasthenia gravis. Ann N Y Acad Sci. 1976;274:659–676. doi: 10.1111/j.1749-6632.1976.tb47724.x. [DOI] [PubMed] [Google Scholar]
- OOSTERHUIS H. J. STUDIES IN MYASTHENIA GRAVIS. 1. A CLINICAL STUDY OF 180 PATIENTS. J Neurol Sci. 1964 Nov-Dec;1(6):512–546. doi: 10.1016/0022-510x(64)90171-6. [DOI] [PubMed] [Google Scholar]
- Strober W., Wochner R. D., Carbone P. P., Waldmann T. A. Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest. 1967 Oct;46(10):1643–1656. doi: 10.1172/JCI105656. [DOI] [PMC free article] [PubMed] [Google Scholar]